Differences in Drug Poisonings Among Those Who Identify as Transgender Compared to Cisgender: An Analysis of the Toxicology Investigators Consortium (ToxIC) Core Registry, United States 2017-2021.

Autor: Magnusson K; Strategic Innovative Solutions LLC (SIS), Clearwater, Florida., Glidden E; National Network of Public Health Institutes (NNPHI), New Orleans, Louisiana; National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia., Mustaquim D; National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia., Welder LE; National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia., Stokes EK; National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia., Beauchamp GA; Lehigh Valley Health Network/ USF Morsani College of Medicine, Allentown, Pennsylvania., Greenberg MR; Lehigh Valley Health Network/ USF Morsani College of Medicine, Allentown, Pennsylvania. Electronic address: Marna.Greenberg@lvhn.org., Aldy K; American College of Medical Toxicology (ACMT), Phoenix, Arizona., Mazzaccaro RJ; Lehigh Valley Health Network/ USF Morsani College of Medicine, Allentown, Pennsylvania., Careyva BA; Lehigh Valley Health Network/ USF Morsani College of Medicine, Allentown, Pennsylvania., Sabino JN; Lehigh Valley Health Network/ USF Morsani College of Medicine, Allentown, Pennsylvania., Fikse DJ; Lehigh Valley Health Network/ USF Morsani College of Medicine, Allentown, Pennsylvania., McLain K; Lehigh Valley Health Network/ USF Morsani College of Medicine, Allentown, Pennsylvania., Amaducci AM; Lehigh Valley Health Network/ USF Morsani College of Medicine, Allentown, Pennsylvania.
Jazyk: angličtina
Zdroj: Clinical therapeutics [Clin Ther] 2024 Sep 18. Date of Electronic Publication: 2024 Sep 18.
DOI: 10.1016/j.clinthera.2024.08.018
Abstrakt: Purpose: In this manuscript, the abbreviation TG is defined as persons who identify as transgender, GNC is defined as persons who identify as gender nonconforming, and CG is defined as persons who identify as cisgender. TG and GNC (e.g., nonbinary), are those whose gender identity and sex assigned at birth do not align, as opposed to CG. This study describes drug poisonings among TG, GNC, and CG captured in the Toxicology Investigators Consortium (ToxIC) Core Registry during 2017-2021.
Methods: Authors conducted a secondary data analysis of medical toxicology physician consultations involving intentional exposures (i.e., use with the knowledge of the exposed person) within the ToxIC Core Registry from 2017 through 2021. Demographic characteristics, exposure intent, and reported drug classes are reported by gender identity and sex assigned at birth.
Findings: From a total of 15,800 medical toxicology consultations, 213 (1.3%) involved both TG (n = 187, 1.2%) and GNC (n = 26, 0.2%), and 15,587 (98.7%) involved CG. Among TG, 128 (68.8%) were transgender men, 58 (31.2%) transgender women. Sixty-two percent of TG/GNC (n = 132) and 34.8% of CG (n = 5,428) were aged ≤18 years. Reported intent for exposure (i.e., self-harm and misuse/harmful use) differed proportionally across both sexes assigned at birth and gender identity among transgender men and cisgender men.
Implications: In the ToxIC Core Registry, the consultations varied proportionally by age group across TG/GNC and CG, with more than half of TG/GNC aged ≤18 years. The proportion of consultations also varied by intent across TG/GNC and CG. Further research to delineate differences between TG/GNC and CG could increase knowledge in prevention, assessment, and treatment of drug poisonings in this population.
Competing Interests: Declaration of competing interest None.
(Copyright © 2024 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: